In our study, reduced E-Cadherin expression was linked to high grade, triple negative receptor status and poor prognosis in invasive breast carcinoma of no special type, triple negative receptor status in lobular breast cancer, advanced pT stage and lymph node metastasis in colorectal cancer as well as prostate cancer progression. Here, CDH1 is linked to Hereditary breast cancer.